Tonix Pharmaceuticals Announces Clearance of IND for TNX-102 SL for Treatment of Alcohol Use Disorder

NEXT STORY
Adaptive Biotechnologies Receives Expanded FDA Clearance for the clonoSEQ® Assay to Assess Minimal Residual Disease (MRD) in Patients with Chronic Lymphocytic Leukemia
PREV STORY
Aeterna Zentaris Reports Second Quarter 2020 Financial Results and Provides Business Update
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Telix Pharmaceuticals submits European marketing authorisation application for prostate cancer imaging product

author_avatar
NASDAQ Market News

Digital PCR Market to Exhibit 17.2% CAGR by 2026 Owing to Improving Healthcare Facilities in Developing Nations, reports Fortune Business Insights™

author_avatar
NASDAQ Market News

Biothera Pharmaceuticals Presents Translational Data from Ongoing Clinical Trials Showing Imprime PGG in Combination with Merck’s KEYTRUDA® (pembrolizumab) Drives Innate and Adaptive Immune Responses in Tumors

author_avatar
NASDAQ Market News